1. Home
  2. NVRI vs WVE Comparison

NVRI vs WVE Comparison

Compare NVRI & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enviri Corporation

NVRI

Enviri Corporation

HOLD

Current Price

$19.39

Market Cap

582.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.65

Market Cap

673.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVRI
WVE
Founded
1853
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.1M
673.9M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
NVRI
WVE
Price
$19.39
$3.65
Analyst Decision
Buy
Strong Buy
Analyst Count
3
21
Target Price
★ $28.67
$17.00
AVG Volume (30 Days)
253.4K
★ 2.9M
Earning Date
11-05-2026
10-27-2026
Dividend Yield
★ 77.72%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $3,704,000.00
Revenue This Year
N/A
$47.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 149.43
52 Week Low
$11.15
$3.04
52 Week High
$24.20
$21.73

Technical Indicators

Market Signals
Indicator
NVRI
WVE
Relative Strength Index (RSI) 44.91 51.75
Support Level $18.77 $3.04
Resistance Level $19.74 $4.07
Average True Range (ATR) 0.82 0.19
MACD 0.02 0.08
Stochastic Oscillator 43.00 86.30

Price Performance

Historical Comparison
NVRI
WVE

About NVRI Enviri Corporation

Enviri Corp provides environmental and operational solutions to the metal and rail industries. It is based in Philadelphia, Pennsylvania, and operates in more than 30 countries. The company leverages industrial expertise to help customers improve operational performance, recover value from byproducts, enhance sustainability, and maintain critical infrastructure. Its divisions are Harsco Environmental and Harsco Rail, which combine deep operational capabilities with technologies and world-wide scale to deliver long-term value for customers, communities, and shareholders.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: